J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline

November 28, 2012 5:47 PM EST Send to a Friend
Janssen Research & Development, LLC (Janssen) today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login